FDG-PET in inflammatory bowel disease

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 53, Issue 1, 2009, Pages 64-71

  Spier, B J ^a   Perlman, S B ^a   Reichelderfer, M ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Colitis, ulcerative; Computed tomography; Crohn disease; Inflammatory bowel diseases; Tomography, emission computed

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; TECHNETIUM 99M;

COLON BIOPSY; COLONOSCOPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST RADIOGRAPHY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DRUG UPTAKE; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; IMAGE DISPLAY; INCIDENTAL FINDING; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; PROTEIN BLOOD LEVEL; RADIATION EXPOSURE; REVIEW; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; THROMBOCYTE COUNT; ULCERATIVE COLITIS;

FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENTAL FINDINGS; INFLAMMATORY BOWEL DISEASES; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 65749099559     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Hawkins RA, Hoh C, Glaspy J, Choi Y, Dahlbom M, Rege S et al. The role of positron emission tomography in oncology and other whole-body applications. Semin Nucl Med 1992;22:268-84.
2. Rice TW. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am 2000;10:471-85.
3. Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004;22:4357-68.
4. Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA, Bowel hot spots at PET-CT. Radiographics 2007;27:145-59.
5. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32:623-48.
6. Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology 2002;224:783-7.
7. 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med. 2004;45:1804-10.
8. Jaruskova M, Belohlavek O. Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states. Eur J Nucl Med Mol Imaging 2006;33:913-8.
9. Bicik I, Bauerfeind P, Breitbach T, von Schulthess GK, Fried M. Inflammatory bowel disease activity measured by positron-emission tomography. Lancet 1997;350:262.
10. 18F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease. Lancet 1999;354:836-7.
11. 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann N Y Acad Sci 2006;1072:379-85.
12. Das CJ, Makharia G, Kumar R, Chawla M, Goswami P, Sharma R et al. PET-CT enteroclysis: a new technique for evaluation of inflammatory diseases of the intestine. Eur J Nucl Med Mol Imaging 2007;34:2106-14.
13. 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol 2002;97:1978-85.
14. 18F] fluoro-D-glucose-labeled white blood cells. Mol Imaging Biol 2003;5:271-7.
15. Lemberg DA, Issenman RM, Cawdron R, Green T, Mernagh J, Skehan SJ et al. Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis 2005;11:733-8.
16. Louis E, Ancion G, Colard A, Spote V, Belaiche J, Hustinx R. Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT. J Nucl Med 2007;48:1053-9.
17. Meisner RS, Spier BJ, Einarsson S, Roberson EN, Perlman SB, Bianco JA et al. Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflamm Bowel Dis 2007;13:993-1000.
18. Allan RA, Imaging in inflammatory bowel disease. Imaging 2001;13:272-84.
19. 99mTc-HMPAO white blood cell scintigraphy. J Nucl Med 2004;45:1698-704.
20. 99mTc white blood cells. Radiology 1999;212:507-13.
21. Spier BJ, Johnson EA, Einstein MM, Pearlman SB, Jaskowiak C, Bassiouni M et al. PetCT: a direct noninvasive measure of inflammation in inflammatory bowel disease (IBD)? Inflamm Bowel Dis 2008;14:S26-S27.